SCHEMBL4513948

SCHEMBL4513948

Cc1c(C(=O)Cl)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)s1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 19/20 0.70
CNR1 P21554 13/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1985291 0.91 CNR2 (0.70) CNR2CNR1
SCHEMBL4508744 0.89 CNR2 (0.70) CNR2CNR1
SCHEMBL1984928 0.86 CNR1 (0.65) CNR2CNR1
SCHEMBL4512872 0.85 CNR1 (0.72) CNR2CNR1
SCHEMBL4531313 0.84 CNR1 (0.69) CNR2CNR1
SCHEMBL1984585 0.84 CNR1 (0.69) CNR2CNR1
SCHEMBL1984625 0.83 CNR1 (1.00) CNR2CNR1
SCHEMBL1983461 0.83 CNR1 (0.61) CNR2CNR1
SCHEMBL1985982 0.83 CNR2 (0.60) CNR2CNR1
SCHEMBL276817 0.82 CNR2 (0.76) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101528706-A Pyrazole compounds NAT HEALTH RESEARCH INSTITUTES (CN) 2009-09-09 CN disclosed
EP-2084135-A2 PYRAZOLE COMPOUNDS National Health Research Institutes (TW) 2009-08-05 EP disclosed
US-20090042864-A2 PYRAZOLE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2009-02-12 US disclosed
WO-2008060771-A2 PYRAZOLE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-22 WO disclosed
US-20080090809-A1 PYRAZOLE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042864-A2 PYRAZOLE COMPOUNDS CNR2, CNR1, GPR18 CNR2 1/4885CNR1 2/4885
US-20080090809-A1 PYRAZOLE COMPOUNDS CNR2, CNR1, GPR18 CNR2 1/4885CNR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.